Chemical compounds 572

US8143290B2 · kind B2 · utility

Assignees

• ASTRAZENECA AB · SE
• Bayer Schering Pharma AG · DE

Inventors

• Markus Berger · Berlin, DE
• Jan Dahmen · Lund, SE
• Karl Edman · Timrå, SE
• Anders Eriksson · Lund, SE
• Balint Gabos · Lund, SE
• Thomas Hansson · Lund, SE
• Martin Hemmerling · Timrå, SE
• Krister Henriksson · Lund, SE
• Svetlana Ivanova · Lund, SE
• Matti Lepisto · Lund, SE
• Darren McKerrecher · Macclesfield, GB
• Magnus Munck af Rosenschöld · Lund, SE
• Stinabritt Nilsson · Lund, SE
• Hartmut Rehwinkel · Berlin, DE
• Camilla Taflin · Lund, SE

Key dates

• Filing date: Dec 2, 2010
• Grant date: Mar 27, 2012
• Expiry date: Dec 2, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of formula (I):The present invention relates to novel indazolyl ester or amide derivatives, to pharmaceutical compositions comprising such derivatives, to processes for preparing such novel derivatives and to the use of such derivatives as medicaments.